CRP/albumin ratio as an age-dependent prognostic factor in patients with COVID-19 pneumonia
Abstract
Purpose: The aim of our study was to determine whether C-reactive protein/albumin is an age-related marker in Covid-19 pneumonia.
Materials and Methods: We performed a retrospective research on 296 patients (166 male/130 female) with Covid-19 pneumonia. The participants were divided into two groups as <65 and ≥65 years of age. The need of intensive care unit, pulse steroid requirement and mortality rates were all compared using the The C-reactive protein/albumin ratio.
Results: The C-reactive protein/albumin was found to be high in patients over the age of 65 as well as those under the age of 65 who were admitted to the intensive care unit and was found to be significant in demonstrating mortality in patients aged 65 and over. According to univariate analysis, the C-reactive protein/albumin ratio was statistically significant for the risk of intensive care admission in both patients under 65 and over 65 years of age (OR:1.515 and OR:1.357, respectively). According to multivariate analysis, the CRP/albumin ratio was statistically significant for the risk of intensive care admission, only in patients over the age of 65 (OR:1.209).
Conclusion: The increased C-reactive protein/albumin levels are thought to be useful in predicting the severity of Covid-19, hospitalisation time, and mortality rates. This variable can be calculated and used to predict the clinical course of Covid-19 pneumonia without regard to age.
Keywords
Kaynakça
- 1- Lia T, Lub H and Zhangc W. Clinical observation and management of COVID-19 patients; Emerging Microbes and Infections 2020; 9: 687–690. (PMID: 32208840)
- 2- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-513. (PMID: 32007143)
- 3- Feketea GM, Vlacha V. The Diagnostic Significance of Usual Biochemical Parameters in Coronavirus Disease 19 (COVID-19): Albumin to Globulin Ratio and CRP to Albumin Ratio; Front Med (Lausanne) 2020;7:566591.3. (PMID: 33224959)
- 4- Pepys M.B, Hirschfield G.M. C-reactive protein: a critical update. J. Clin. Invest. 2013;111:1805–1812. (PMID: 12813013)
- 5- Mooiweer E, Luijk B, Bonten M.J, Ekkelenkamp M.B. C-Reactive protein levels but not CRP dynamics predict mortality in patients with pneumococcal pneumonia. J. Infect. 2011;62:314–316. (PMID: 21281676)
- 6- Hahn W.H, Song J.H, Kim H, Park S. Is procalcitonin to C-reactive protein ratio useful for the detection of late onset neonatal sepsis? J. Matern. Fetal. Neonatal. Med. 2018;31:822–826. (PMID: 28277917)
- 7- Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive p rotein/albumin ratio as a predictor of patient outcome. Clinical Medicine. 2009;9(1):30–33. (PMID: 19271597)
- 8- Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;120:435–446. (PMID: 17313487)
- 9- Imam Z, Odish F, Gill I, O'Connor D, Armstrong J, Vanood A, Ibironke O, Hanna A, Ranski A, Halalau A. Olde et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med. 2020 Oct;288(4):469-476. (PMID: 32498135)
- 10- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28; 395(10229):1054-1062. (PMID: 32171076)
